Novel AAV2-FGF18 Gene Therapy Promotes Cartilage Anabolism

Vet Comp Orthop Traumatol 2023; 36(05): A1-A27
DOI: 10.1055/s-0043-1775608

Podium Abstracts

Authors

A. Goraltchouk

¹Remedium Bio, Inc., Needham, Massachusetts, United States
J.M. Hollander

²Department of Immunology, Tufts University School of Medicine, Boston, Massachusetts, United States
F. Luppino

¹Remedium Bio, Inc., Needham, Massachusetts, United States
L. Zeng

²Department of Immunology, Tufts University School of Medicine, Boston, Massachusetts, United States
A. Seregin

¹Remedium Bio, Inc., Needham, Massachusetts, United States